Table 4.
Variables | OS | Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|---|---|
1-yr | 5-yr | HR(95%CI) | P value | HR(95%CI) | P value | |
TACE | 88.9 | 66.7 | 0.214(0.046-0.995) | 0.032 | 0.105(0.014-0.774) | 0.027 |
APE | 73.3 | 26.7 | 0.435(0.140-1.359) | 0.141 | NS | |
AJCC stage 3 to 4 | 46.2 | 7.7 | 7.607(1.624-35.633) | 0.003 | NS | |
LNM | 50.0 | 0 | 4.129(1.188-14.357) | 0.017 | NS |
OS: overall survival, HR: hazard ratio, CI: confidence interval, TACE: transarterial chemoembolization, APE: arterial phase enhancement, NS: not significant, AJCC: American Joint Committee on Cancer, LNM: lymph node metastasis